These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12408757)

  • 1. Pre-clinical study on tumor vasoactive intestinal peptide receptor scintigraphy.
    Wang X; Zhang M; Yang Z; Lin B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):331-4. PubMed ID: 12408757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies.
    Pallela VR; Thakur ML; Chakder S; Rattan S
    J Nucl Med; 1999 Feb; 40(2):352-60. PubMed ID: 10025846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of VIP binding sites in opossum internal anal sphincter circular smooth muscle.
    Chakder S; Rattan S
    J Pharmacol Exp Ther; 1995 Jan; 272(1):385-91. PubMed ID: 7815354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
    Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complete substitutional analysis of VIP for better tumor imaging properties.
    Bhargava S; Licha K; Knaute T; Ebert B; Becker A; Grötzinger C; Hessenius C; Wiedenmann B; Schneider-Mergener J; Volkmer-Engert R
    J Mol Recognit; 2002; 15(3):145-53. PubMed ID: 12203840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and functional expression of a VIP-specific receptor.
    Zhou H; Huang J; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G728-34. PubMed ID: 16959956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
    Igarashi H; Ito T; Mantey SA; Pradhan TK; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2005 Oct; 315(1):370-81. PubMed ID: 15994369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling and in vitro and in vivo characterization of [18F]FB-[R(8,15,21), L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors.
    Cheng D; Yin D; Li G; Wang M; Li S; Zheng M; Cai H; Wang Y
    Chem Biol Drug Des; 2006 Dec; 68(6):319-25. PubMed ID: 17177894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.
    Kalamatianos T; Kalló I; Piggins HD; Coen CW
    J Comp Neurol; 2004 Jul; 475(1):19-35. PubMed ID: 15176082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.